G1 Therapeutics Inc.(GTHX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GTHX G1 Therapeutics Inc.

盘后交易 07-23 19:20:32 EDT

3.86

+0.19

+5.18%

盘后3.90

+0.04+1.04%

16:22 EDT

最高3.90	最低3.61	成交量73.64万
今开3.63	昨收3.67	日振幅7.89%
总市值2.02亿	流通市值1.69亿	总股本5,228万
成交额279.56万	换手率1.68%	流通股本4,382万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GTHX","market":"US","secType":"STK","nameCN":"G1 Therapeutics Inc.","latestPrice":3.86,"timestamp":1721764800000,"preClose":3.67,"halted":0,"volume":736356,"hourTrading":{"tag":"盘后","latestPrice":3.9,"preClose":3.86,"latestTime":"16:22 EDT","volume":11140,"amount":42928.641690000004,"timestamp":1721766135060},"delay":0,"floatShares":43821906,"shares":52281391,"eps":-0.592624,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.19,"latestTime":"07-23 19:20:32 EDT","open":3.63,"high":3.9,"low":3.6105,"amount":2795647.716888,"amplitude":0.078883,"askPrice":3.9,"askSize":448,"bidPrice":3.52,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.592624,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1721779200000},"adr":0,"listingDate":1494993600000,"adjPreClose":3.67,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":3.9,"preClose":3.86,"latestTime":"16:22 EDT","volume":11140,"amount":42928.641690000004,"timestamp":1721766135060},"volumeRatio":0.697316,"impliedVol":0.3392,"impliedVolPercentile":0.0238},"requestUrl":"/m/hq/s/GTHX","defaultTab":"news","newsList":[{"id":"2446558943","title":"G1 Therapeutics, Inc.盘中异动 早盘股价大涨5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446558943","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446558943?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:35","pubTimestamp":1719495323,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日21时35分，G1 Therapeutics, Inc.股票出现波动，股价快速上涨5.78%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。消息层面，截至21时35分，《TD Cowen维持G1 Therapeutics买入评级》资讯为影响G1 Therapeutics, Inc.的重要信息。该信息摘要如下：TD Cowen分析师Joseph Thome维持$G1 Therapeutics $买入评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062721352396817824&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062721352396817824&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTHX","BK4139","LENZ"],"gpt_icon":0},{"id":"2446849755","title":"G1 Therapeutics, Inc.盘中异动 早盘股价大跌8.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446849755","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446849755?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:39","pubTimestamp":1719322768,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时39分，G1 Therapeutics, Inc.股票出现波动，股价大幅下跌8.11%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Glycomimetics, Inc.、Senti Biosciences, Inc.、Anew Medical, Inc.涨幅较大，Glycomimetics, Inc.、Effector Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为99.32%、88.15%、63.92%，振幅较大的相关个股有Cingulate Inc.、Werewolf Therapeutics, Inc.、Glycomimetics, Inc.，振幅分别为19.77%、16.85%、15.94%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。其产品COSELA显示有助于保护骨髓免受化疗的损害。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625213928af8f2079&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625213928af8f2079&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTHX","LENZ","BK4139"],"gpt_icon":0},{"id":"2445072747","title":"G1 Therapeutics, Inc.盘中异动 股价大跌33.48%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445072747","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445072747?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:32","pubTimestamp":1719235930,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时32分，G1 Therapeutics, Inc.股票出现异动，股价大幅下跌33.48%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Revelation Biosciences, Inc.、阿里拉姆制药涨幅较大，Revelation Biosciences, Inc.、Gri Bio, Inc.、Effector Therapeutics, Inc.较为活跃，换手率分别为336.94%、43.78%、33.44%，振幅较大的相关个股有Revelation Biosciences, Inc.、Psyence Biomedical Ltd.、G1 Therapeutics, Inc.，振幅分别为23.70%、11.62%、10.20%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062421321095d2b57f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062421321095d2b57f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GTHX","BK4139"],"gpt_icon":0},{"id":"2445027534","title":"更新版 1-G1 Therapeutics 公司的乳腺癌药物在晚期试验中失败","url":"https://stock-news.laohu8.com/highlight/detail?id=2445027534","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445027534?lang=zh_cn&edition=full","pubTime":"2024-06-24 19:11","pubTimestamp":1719227494,"startTime":"0","endTime":"0","summary":"     路透6月24日 - G1 Therapeutics   周一表示，其治疗 一种罕见的侵袭性乳腺癌 的药物 在一项晚期试验中没有达到总生存期的主要目标。G1公司的药物trilaciclib在187名转移性三阴性乳腺癌患者中进行了试验，服药患者的中位总生存期为17.4个月，而未接受治疗的患者的总生存期为17.8个月。首席执行官杰克-贝利说，G1 公司将评估 trilaciclib 的其他用途，并将寻求 合作伙伴在全球范围内扩大其使用范围。G1 therapeutics公司的股票在盘前交易中下跌了31.8% 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTHX","BK4139","LENZ"],"gpt_icon":0},{"id":"2445022654","title":"BUZZ-G1 Therapeutics 因乳腺癌药物未能达到主要研究目标而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2445022654","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445022654?lang=zh_cn&edition=full","pubTime":"2024-06-24 18:59","pubTimestamp":1719226782,"startTime":"0","endTime":"0","summary":"    6月24日 - ** G1 Therapeutics   股价在盘前交易中下跌18.1%，至2.03美元 ** 该公司的药物trilaciclib未能达到一项晚期研究的主要目标，该研究针对的是一种会扩散到身体其他部位的乳腺癌患者。** 截至上次收盘，GHTX 年累计下跌约 19","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","LENZ","GTHX","BK4139"],"gpt_icon":0},{"id":"2445302480","title":"G1 Therapeutics 的乳腺癌疗法未能通过后期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2445302480","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445302480?lang=zh_cn&edition=full","pubTime":"2024-06-24 18:36","pubTimestamp":1719225408,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透6月24日 - G1 Therapeutics   周一表示，其治疗一种乳腺癌的疗法在一项晚期试验中没有达到总生存期的主要目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTHX","BK4139","LENZ"],"gpt_icon":0},{"id":"2443763104","title":"G1 Therapeutics, Inc.盘中异动 急速上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443763104","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443763104?lang=zh_cn&edition=full","pubTime":"2024-06-14 01:38","pubTimestamp":1718300314,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日01时38分，G1 Therapeutics, Inc.股票出现异动，股价快速上涨5.14%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。消息层面，截至01时38分，《Needham维持G1 Therapeutics买入评级，维持目标价12美元》资讯为影响G1 Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614013835aef4d85b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614013835aef4d85b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTHX","LENZ","BK4139"],"gpt_icon":0},{"id":"2439504867","title":"G1 Therapeutics, Inc.盘中异动 下午盘股价大跌5.00%报3.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439504867","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439504867?lang=zh_cn&edition=full","pubTime":"2024-05-30 02:48","pubTimestamp":1717008510,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日02时48分，G1 Therapeutics, Inc.股票出现波动，股价快速下挫5.00%。截至发稿，该股报3.23美元/股，成交量74.6078万股，换手率1.43%，振幅4.47%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.08%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。其产品COSELA显示有助于保护骨髓免受化疗的损害。该信息摘要如下：HC Wainwright & Co.：重申G1 Therapeutics评级，由买入调整至买入评级, 目标价由9.00美元调整至9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530024830af8af26a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530024830af8af26a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GTHX"],"gpt_icon":0},{"id":"2439001933","title":"HC Wainwright & Co.：重申G1 Therapeutics(GTHX.US)评级，由买入调整至买入评级, 目标价由9.00美元调整至9.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2439001933","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439001933?lang=zh_cn&edition=full","pubTime":"2024-05-29 00:45","pubTimestamp":1716914755,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申G1 Therapeutics(GTHX.US)评级，由买入调整至买入评级, 目标价由9.00美元调整至9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405290046009efac8a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405290046009efac8a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GTHX"],"gpt_icon":0},{"id":"2438372152","title":"G1 Therapeutics, Inc.盘中异动 急速下跌5.38%报3.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438372152","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438372152?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:36","pubTimestamp":1716903413,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时36分，G1 Therapeutics, Inc.股票出现波动，股价大幅跳水5.38%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.09%。其相关个股中，Insmed Incorporated、Calliditas Therapeutics Ab、Protagenic Therapeutics Inc C/Wts 29/04/2026 涨幅较大，Exicure, Inc.、Jaguar Health, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为20.95%、8.10%、7.52%，振幅较大的相关个股有Exicure, Inc.、Corcept医疗、Renovaro Inc.，振幅分别为25.45%、13.15%、12.68%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。其产品COSELA显示有助于保护骨髓免受化疗的损害。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213653af8ab327&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213653af8ab327&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","GTHX"],"gpt_icon":0},{"id":"2437951182","title":"G1 Therapeutics, Inc.盘中异动 早盘急速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437951182","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437951182?lang=zh_cn&edition=full","pubTime":"2024-05-22 21:31","pubTimestamp":1716384712,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日21时31分，G1 Therapeutics, Inc.股票出现波动，股价快速拉升5.08%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Mustang Bio, Inc.、Engene Holdings Inc C/Wts 31/10/2028  Cl A涨幅较大，Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Coeptis Therapeutics Holdings, Inc.较为活跃，换手率分别为183.94%、89.17%、32.34%，振幅较大的相关个股有Rezolute, Inc.、Nutriband Inc C/Wts 、Sol-Gel Technologies Ltd.，振幅分别为13.00%、12.90%、10.55%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。其产品COSELA显示有助于保护骨髓免受化疗的损害。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522213152af89add4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522213152af89add4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GTHX"],"gpt_icon":0},{"id":"2437019266","title":"BUZZ-G1 Therapeutics 因达成放射保护药物许可协议而攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2437019266","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437019266?lang=zh_cn&edition=full","pubTime":"2024-05-22 19:31","pubTimestamp":1716377462,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    5月22日 - ** 癌症疗法开发商 G1 Therapeutics   的股价盘前上涨 4% 至 4.71 美元** G1将与Deimos Biosciences合作 (link)，就用于放射保护的药物lerociclib达成全球许可协议，亚太地区除外。 ** 放射保护药物有助于保护健康组织免受放射治疗引起的某些副作用的影响** 除了获得 lerociclib 年累计净销售额 20% 的特许权使用费外，G1 还将获得占 Deimos 已发行股本 10% 的普通股。** 截至上次收盘，GTHX 年累计上涨 48.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTHX","LENZ","BK4139","BUZZ"],"gpt_icon":0},{"id":"2437268270","title":"G1 Therapeutics-预计将在全面摊薄的基础上获得占Deimos已发行股本10％的Deimos普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=2437268270","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437268270?lang=zh_cn&edition=full","pubTime":"2024-05-22 18:45","pubTimestamp":1716374732,"startTime":"0","endTime":"0","summary":"G1 Therapeutics-预计将在全面摊薄的基础上获得占Deimos已发行股本10％的Deimos普通股","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052218453587873de4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052218453587873de4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GTHX"],"gpt_icon":0},{"id":"2433434369","title":"G1 Therapeutics, Inc.2024财年第一财季实现净利润-10.22百万美元，同比增加62.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433434369","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433434369?lang=zh_cn&edition=full","pubTime":"2024-05-06 00:19","pubTimestamp":1714925977,"startTime":"0","endTime":"0","summary":"3月31日，G1 Therapeutics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-10.22百万美元，同比增加62.97%；其中营业收入为14.48百万美元，同比增加11.81%，每股基本收益为-0.20美元。机构评级：截至2024年3月31日，当前有4家机构对G1 Therapeutics, Inc.目标价做出预测，其中目标均价为8.50美元，其中最低目标价为5.00美元，最高目标价为12.00美元。公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050600194687d52a16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050600194687d52a16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTHX","LENZ"],"gpt_icon":0},{"id":"2432118970","title":"G1 Therapeutics, Inc.盘中异动 大幅拉升5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432118970","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432118970?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:31","pubTimestamp":1714743072,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时31分，G1 Therapeutics, Inc.股票出现波动，股价快速拉升5.18%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。该信息摘要如下：HC Wainwright & Co.：重申G1 Therapeutics评级，由买入调整至买入评级, 目标价9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032131137a57fb0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032131137a57fb0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTHX","BK4139","LENZ"],"gpt_icon":0},{"id":"2431866589","title":"G1 Therapeutics, Inc.盘中异动 股价大跌5.01%报3.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431866589","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431866589?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:44","pubTimestamp":1714398252,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时44分，G1 Therapeutics, Inc.股票出现波动，股价大幅跳水5.01%。截至发稿，该股报3.79美元/股，成交量8.2342万股，换手率0.16%，振幅5.01%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。其相关个股中，Immunitybio, Inc.、Soleno Therapeutics, Inc.、Zyversa Therapeutics, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为615.51%、27.66%、14.27%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Immunitybio, Inc.、Eliem Therapeutics, Inc，振幅分别为33.33%、20.98%、18.59%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921441287e84bf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921441287e84bf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTHX","BK4139","LENZ"],"gpt_icon":0},{"id":"2431486867","title":"G1 Therapeutics Inc   预计每股亏损21美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431486867","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431486867?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:21","pubTimestamp":1714396915,"startTime":"0","endTime":"0","summary":"   * G1 Therapeutics Inc    预计将在5月1日公布截至2024年3月31日的季度收入报告。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于北卡罗来纳州三角研究园的公司的营收有望从去年同期的1295万美元增长17.9%，达到1525.9万美元。* LSEG 分析师对 G1 Therapeutics Inc 的平均预期是每股亏损 21 美分。* 华尔街对 G1 Therapeutics Inc 的 12 个月目标价中位数为 8.50 美元，高于其上次收盘价 3.99 美元。4月29日 - 以往季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","GTHX"],"gpt_icon":0},{"id":"2429118955","title":"G1 Therapeutics, Inc.盘中异动 股价大涨5.24%报4.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429118955","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429118955?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:54","pubTimestamp":1713880488,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时54分，G1 Therapeutics, Inc.股票出现波动，股价急速上涨5.24%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.18%。其相关个股中，Palisade Bio, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd涨幅较大，Palisade Bio, Inc.、Silo Pharma, Inc.、Nkgen Biotech, Inc.较为活跃，换手率分别为1478.10%、165.91%、26.03%，振幅较大的相关个股有Palisade Bio, Inc.、Immunitybio, Inc.、Moolec Science Sa C/Wts ，振幅分别为32.86%、25.10%、23.24%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232154487a54eea6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232154487a54eea6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GTHX"],"gpt_icon":0},{"id":"2428345662","title":"G1 Therapeutics, Inc.盘中异动 大幅拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428345662","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428345662?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:36","pubTimestamp":1713360965,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时36分，G1 Therapeutics, Inc.股票出现波动，股价大幅上涨5.15%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Psyence Biomedical Ltd C/Wts 25/01/2029、Vanda Pharmaceuticals Inc.涨幅较大，Clearmind Medicine Inc.、Novabay Pharmaceuticals, Inc.、Longeveron Inc.较为活跃，换手率分别为25.54%、22.73%、20.12%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Jaguar Health, Inc.、Viracta Therapeutics, Inc.，振幅分别为25.30%、16.55%、15.75%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041721360579214110&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041721360579214110&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","GTHX"],"gpt_icon":0},{"id":"2427873061","title":"G1 Therapeutics, Inc.盘中异动 快速下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427873061","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427873061?lang=zh_cn&edition=full","pubTime":"2024-04-13 00:32","pubTimestamp":1712939567,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日00时32分，G1 Therapeutics, Inc.股票出现异动，股价大幅跳水5.02%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.25%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。该信息摘要如下：Needham：重申G1 Therapeutics评级，由买入调整至买入评级, 目标价12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041300324787e7ffeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041300324787e7ffeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","GTHX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.g1therapeutics.com","stockEarnings":[{"period":"1week","weight":0.1327},{"period":"1month","weight":0.4798},{"period":"3month","weight":-0.1241},{"period":"6month","weight":-0.0027},{"period":"1year","weight":0.5103},{"period":"ytd","weight":0.2033}],"compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0186},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.1427},{"period":"1year","weight":0.2266},{"period":"ytd","weight":0.1669}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"G1 Therapeutics, Inc.于2008年5月19日以“G-Zero Therapeutics, Inc.”的名义，以特拉华州的法律注册成立。2012年9月，他们更名为“G1治疗公司”。该公司是一家商业化阶段的生物制药公司，专注于开发和商业化治疗癌症患者的新型小分子疗法。美国食品和药物管理局批准的第一个产品COSELA（trilaciclib）是第一个也是唯一一个被证明可以主动帮助保护骨髓免受化疗（骨髓保护）损害的疗法，也是几十年来管理骨髓保护的第一个创新。2022年7月，COSELA（注射用盐酸曲拉西利布）获国家药品监督管理局有条件批准在中国上市。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.163982},{"month":2,"riseRate":0.142857,"avgChangeRate":-0.143278},{"month":3,"riseRate":0.428571,"avgChangeRate":0.000021},{"month":4,"riseRate":0.571429,"avgChangeRate":0.00162},{"month":5,"riseRate":0.428571,"avgChangeRate":0.019708},{"month":6,"riseRate":0.625,"avgChangeRate":0.068331},{"month":7,"riseRate":0.375,"avgChangeRate":0.057512},{"month":8,"riseRate":0.714286,"avgChangeRate":0.189478},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.118075},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.046198},{"month":11,"riseRate":0.428571,"avgChangeRate":0.013336},{"month":12,"riseRate":0.285714,"avgChangeRate":0.000011}],"exchange":"NASDAQ","name":"G1 Therapeutics Inc.","nameEN":"G1 Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"G1 Therapeutics Inc.(GTHX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供G1 Therapeutics Inc.(GTHX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"G1 Therapeutics Inc.,GTHX,G1 Therapeutics Inc.股票,G1 Therapeutics Inc.股票老虎,G1 Therapeutics Inc.股票老虎国际,G1 Therapeutics Inc.行情,G1 Therapeutics Inc.股票行情,G1 Therapeutics Inc.股价,G1 Therapeutics Inc.股市,G1 Therapeutics Inc.股票价格,G1 Therapeutics Inc.股票交易,G1 Therapeutics Inc.股票购买,G1 Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"G1 Therapeutics Inc.(GTHX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供G1 Therapeutics Inc.(GTHX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}